At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field. Volume 21, No 5 May 2014 ISSN: 0969-7128 EISSN: 1476-5462 2012 Impact Factor 4.321* 70/290 Biochemistry & Molecular Biology 22/159 Biotechnology & Applied Microbiology 33/161 Genetics & Heredity 25/121 Medicine, Research & Experimental Editors: J Glorioso, USA N Lemoine, UK *2012 Journal Citation Reports Science Edition (Thomson Reuters, 2013) Download the presentation from our How to Get Published Session. (281 kB) Open Gene Therapy now offers authors the option to publish their articles with immediate open access upon publication. Open access articles will also be deposited on PubMed Central at the time of publication and will be freely available immediately. Find out more from our FAQs page. Reviews by top researchers in the field. See the recent Progress and Prospects articles. Essential topics explored in depth in Gene Therapy Special Issues. See the original post: Gene Therapy - Nature … Continue reading →

Spark Therapeutics, a gene therapy medical company, this week signed an agreement for a headquarters in West Philadelphia. Spark Therapeutics, spun out of Children's Hospital of Philadelphia in October with $50 million in capital, will build out a 28,000-square-foot facility at 3737 Market St. to house its business operations, clinical research and development, and manufacturing. Jeffrey D. Marrazzo, cofounder and chief executive, said the new facility "will support the continued expansion of our team and expand our manufacturing capacity to support our clinical development and commercial plans." Spark anticipates moving into its new headquarters and expanding to 50 full-time employees by the end of 2014. Spark is preparing to complete clinical development of its lead, Phase 3 clinical program to address inherited retinal dystrophies caused by mutations in the RPE65 gene. - Erin Arvedlund Excerpt from: Spark Therapeutics to open headquarters in West Philadelphia … Continue reading →